AMLX - Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 9 2024 in Amylyx Lawsuit – AMLX | Benzinga
NEW YORK, April 04, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Amylyx Pharmaceuticals, Inc. ("Amylyx" or the "Company") (NASDAQ:AMLX) of a class action securities lawsuit.
CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Amylyx investors who were adversely affected by alleged securities fraud between November 11, 2022 and November 8, 2023. Follow the link below to get more information and be contacted by a member of our team:
https://zlk.com/pslra-1/amylyx-lawsuit-submission-form?prid=74060&wire=3
AMLX investors may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.
CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (i) defendants had overstated commercial prospects RELYVRIO, a dual ...